Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29536407 | 0.74 | ALDH1A1 (0.50) | MAPK1CYP3A4ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL2355429 | 0.74 | ALDH1A1 (0.50) | MAPK1CYP3A4ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL23387011 | 0.74 | CYP3A4 (0.32) | MAPK1CYP3A4ALDH1A1 | |
| SCHEMBL1322094 | 0.73 | CYP1A2 (0.45) | CYP2A6ALDH1A1KDM4ETDP1TSHR | |
| SCHEMBL1047234 | 0.72 | CYP3A4 (0.40) | MAPK1CYP3A4CYP2A6AHRTDP1 | |
| SCHEMBL30335623 | 0.72 | CYP3A4 (0.35) | MAPK1CYP3A4CYP2A6ALDH1A1KDM4E | |
| SCHEMBL15759423 | 0.71 | CYP3A4 (0.34) | MAPK1CYP3A4ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL29368277 | 0.69 | CYP3A4 (0.62) | MAPK1CYP3A4CYP2A6ALDH1A1AHR | |
| SCHEMBL348089 | 0.69 | CYP3A4 (0.62) | MAPK1CYP3A4CYP2A6ALDH1A1AHR | |
| SCHEMBL8088179 | 0.69 | CYP2D6 (0.37) | MAPK1CYP3A4ALDH1A1CYP2D6SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426631-B2 | Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same | BASF SE (DE) | 2013-04-23 | — | — | US | disclosed |
| US-20100304966-A1 | Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same | BASF SE (DE) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100304966-A1 | Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same | CYP51A1, ERG28, CAT | MAPK1 1845/4885CYP3A4 55/4885CYP2A6 279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.